# Alprostadil

## Promostan inj 20mcg

| TAH Drug Code      | [IPROM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPROM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Improvement of symptoms caused by peripheral arterial occlusive diseases. Maintenance of blood flow after vascular reconstructive surgery.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | Peripheral artery occlusive disease (POAD) adult: IVD, 2-3 vial (40-60 mcg) in NS 500 mL IVD > 2 hr. ( infusion rate: 5-10 ng/kg/min) once or twice daily (maximum: 0.6 mcg/kg/hr)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Conditions that may predispose patients to priapism, such as sickle cell anemia or sickle cell trait, multiple myeloma, leukemia, thrombocytopenia, or polycythemia Hypersensitivity to alprostadil Intracavernosal injection is contraindicated with fibrotic conditions of the penis, including cavernosal fibrosis or Peyronie disease, or with anatomical deformation such as angulation Intracavernosal injection is contraindicated with penile implant Men for whom sexual activity is inadvisable or contraindicated Transurethral suppository is contraindicated with abnormal penile anatomy, including urethral stricture, balanitis, severe hypospadias and curvature, and acute or chronic urethritis Transurethral suppository is contraindicated with pregnant sexual partners unless a condom barrier is used |
| Adverse Effects    | Common: Bradyarrhythmia (Neonates, 7%), Hypotension (Adult, up to 3% ; pediatric, 4%), Tachycardia (Neonates, 3%), Flushing (Neonates, 10%), Urethral discomfort (Adult, 12-13%), Pain in penis (Adult, 29-37%), Pain in testicle (Adult, 1-5%), Fever (Neonates, 14%) Serious: Cardiac arrest (Neonates, 1%), Gastrointestinal obstruction (Neonates, 6.8%), Disseminated intravascular coagulation (Neonates, 1%), Infantile cortical hyperostosis, Seizure (Neonates, 4%), Fibrosis of penis (Intracavernous, 3-7.8%), Priapism (Adult, less than 1%), Prolonged erection of penis (Adult, 0.3-4%), Apnea (Neonates, 10-12%)                                                                                                                                                                                               |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/alprostadil-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

